THERAPEUTIKA GEGEN KREBS

Patent europeic · EP3733175 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3733175
Numer da la dumonda
EP18894766
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
01-08-2018
Publitgà
04-11-2020
Concedì
04-10-2023
La protecziun finescha il pli tard
31-07-2038
Proxima taxa annuala scadenta
31-08-2027
Classas IPC
A61K 31/423 (2006.01)
A61P 35/00 (2006.01)
Prioritad
JP 2017253385 28.12.2017
Dumonda PCT
PCT/JP2018/028887 01.08.2018
Publicaziun PCT
WO2019/130637 04.07.2019
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-09-2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. 01-09-2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. 01-09-2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  4. 14-08-2024

    Midada

    Published in Swissreg on 14.08.2024

  5. 01-11-2023

    Represchentant inscrit

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 01.11.2023

  6. 04-10-2023

    Concedì

    Published in Swissreg on 04.10.2023

Partidas

Inventur

FURUSE Junji

Mitaka-shi, Tokyo 181-8611, JP

WEMPE Michael F.

Aurora, CO 80016, US

OKAYASU Isao

Tokyo 168-0072, JP

ENDOU Hitoshi

Yokohama-shi, Kanagawa 230-0046, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.